Noninvasive detection of genetic instability in cells from prostatic secretion as a marker of prostate cancer

European Journal of Internal Medicine

Volumn 12, Issue 1, 2001, Pages 17-19

  Cussenot, Olivier ^a,b,c   Teillac, Pierre ^b   Berthon, Philippe ^a   Latil, Alain ^a  

^a Parc Scientifique de Luminy   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c INSTITUT UNIVERSITAIRE DE FRANCE   (France)

Author keywords

Loss of heterozygosity; Noninvasive approach to prostate cancer diagnosis

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; GENETIC STABILITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; PREDICTION; PROSTATE BIOPSY; PROSTATE CANCER;

EID: 0035140051     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(00)00134-5     Document Type: Article

References (5)

1. Percentage of free serum prostate-specific antigen: a new tool in the early diagnosis of prostatic cancer
2. Loss of heterozygosity at chromosome arm 13q and RB1 status in human prostate cancer
3. Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer
4. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions
5. Differential chromosome allelic imbalance in the progression of human prostate cancer